Description: EDAP TMS SA
EDAP TMS S.A. and its subsidiaries develop, produce, market, distribute, and maintain medical devices for the treatment of urological diseases. It operates in two divisions, High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of certain types of localized tumors using HIFU technology. The HIFU technology enables a surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division offers Ablatherm, an ultrasound guided HIFU device for the treatment of organ-confined prostate cancer. The UDS division produces and markets lithotripters devices for the treatment of urinary tract stones by using ESWL technology. This division manufactures three models of lithotripters: the Sonolith Praktis, the Sonolith Vision, and the Sonolith I-Sys. It also involves in leasing lithotripters, as well as offers disposables, spare parts, and maintenance services. EDAP TMS S.A. serves public and private hospitals, urology clinics, and research institutions. It markets and sells its products through direct marketing, service platform, and sales organization, as well as through third-party distributors and agents worldwide. The company was founded in 1979 and is based in Vaulx-en-Velin, France.